102 related articles for article (PubMed ID: 22650305)
1. Diphenylpyridylethanamine (DPPE) derivatives as cholesteryl ester transfer protein (CETP) inhibitors.
Harikrishnan LS; Finlay HJ; Qiao JX; Kamau MG; Jiang J; Wang TC; Li J; Cooper CB; Poss MA; Adam LP; Taylor DS; Chen AY; Yin X; Sleph PG; Yang RZ; Sitkoff DF; Galella MA; Nirschl DS; Van Kirk K; Miller AV; Huang CS; Chang M; Chen XQ; Salvati ME; Wexler RR; Lawrence RM
J Med Chem; 2012 Jul; 55(13):6162-75. PubMed ID: 22650305
[TBL] [Abstract][Full Text] [Related]
2. Triphenylethanamine Derivatives as Cholesteryl Ester Transfer Protein Inhibitors: Discovery of N-[(1R)-1-(3-Cyclopropoxy-4-fluorophenyl)-1-[3-fluoro-5-(1,1,2,2-tetrafluoroethoxy)phenyl]-2-phenylethyl]-4-fluoro-3-(trifluoromethyl)benzamide (BMS-795311).
Qiao JX; Wang TC; Adam LP; Chen AY; Taylor DS; Yang RZ; Zhuang S; Sleph PG; Li JP; Li D; Yin X; Chang M; Chen XQ; Shen H; Li J; Smith D; Wu DR; Leith L; Harikrishnan LS; Kamau MG; Miller MM; Bilder D; Rampulla R; Li YX; Xu C; Lawrence RM; Poss MA; Levesque P; Gordon DA; Huang CS; Finlay HJ; Wexler RR; Salvati ME
J Med Chem; 2015 Nov; 58(22):9010-26. PubMed ID: 26524347
[TBL] [Abstract][Full Text] [Related]
3. Diphenylpyridylethanamine (DPPE)-based aminoheterocycles as cholesteryl ester transfer protein inhibitors.
Wang Y; Yang W; Finlay HJ; Harikrishnan LS; Jiang J; Kamau MG; Van Kirk K; Nirschl DS; Taylor DS; Chen AY; Yin X; Sleph PG; Yang RZ; Huang CS; Adam LP; Lawrence RM; Wexler RR; Salvati ME
Bioorg Med Chem Lett; 2014 Feb; 24(3):860-4. PubMed ID: 24424134
[TBL] [Abstract][Full Text] [Related]
4. Identification of a potent and metabolically stable series of fluorinated diphenylpyridylethanamine-based cholesteryl ester transfer protein inhibitors.
Miller MM; Liu Y; Jiang J; Johnson JA; Kamau M; Nirschl DS; Wang Y; Harikrishnan L; Taylor DS; Chen AY; Yin X; Seethala R; Peterson TL; Zvyaga T; Zhang J; Huang CS; Wexler RR; Poss MA; Lawrence RM; Adam LP; Salvati ME
Bioorg Med Chem Lett; 2012 Oct; 22(20):6503-8. PubMed ID: 22995620
[TBL] [Abstract][Full Text] [Related]
5. 2D and 3D QSAR models for identifying diphenylpyridylethanamine based inhibitors against cholesteryl ester transfer protein.
Chen M; Yang X; Lai X; Gao Y
Bioorg Med Chem Lett; 2015 Oct; 25(20):4487-95. PubMed ID: 26346366
[TBL] [Abstract][Full Text] [Related]
6. Selective CETP inhibition and PPARalpha agonism increase HDL cholesterol and reduce LDL cholesterol in human ApoB100/human CETP transgenic mice.
Hansen MK; McVey MJ; White RF; Legos JJ; Brusq JM; Grillot DA; Issandou M; Barone FC
J Cardiovasc Pharmacol Ther; 2010 Jun; 15(2):196-202. PubMed ID: 20332533
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and discovery of 2,3-dihydro-3,8-diphenylbenzo[1,4]oxazines as a novel class of potent cholesteryl ester transfer protein inhibitors.
Wang A; Prouty CP; Pelton PD; Yong M; Demarest KT; Murray WV; Kuo GH
Bioorg Med Chem Lett; 2010 Feb; 20(4):1432-5. PubMed ID: 20089400
[TBL] [Abstract][Full Text] [Related]
8. Potent cholesteryl ester transfer protein inhibitors of reduced lipophilicity: 1,1'-spiro-substituted hexahydrofuroquinoline derivatives.
Trieselmann T; Wagner H; Fuchs K; Hamprecht D; Berta D; Cremonesi P; Streicher R; Luippold G; Volz A; Markert M; Nar H
J Med Chem; 2014 Nov; 57(21):8766-76. PubMed ID: 25265559
[TBL] [Abstract][Full Text] [Related]
9. 2-Arylbenzoxazoles as CETP inhibitors: Substitution of the benzoxazole moiety.
Smith CJ; Ali A; Chen L; Hammond ML; Anderson MS; Chen Y; Eveland SS; Guo Q; Hyland SA; Milot DP; Sparrow CP; Wright SD; Sinclair PJ
Bioorg Med Chem Lett; 2010 Jan; 20(1):346-9. PubMed ID: 19914065
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of new tetrahydroquinolines derivatives as CETP inhibitors.
Escribano A; Mateo AI; Martin de la Nava EM; Mayhugh DR; Cockerham SL; Beyer TP; Schmidt RJ; Cao G; Zhang Y; Jones TM; Borel AG; Sweetana SA; Cannady EA; Mantlo NB
Bioorg Med Chem Lett; 2012 Jun; 22(11):3671-5. PubMed ID: 22543028
[TBL] [Abstract][Full Text] [Related]
11. Discovery of hydroxyl 1,2-diphenylethanamine analogs as potent cholesterol ester transfer protein inhibitors.
Jiang J; Finlay H; Johnson JA; Harikrishnan L; Kamau M; Qiao J; Wang T; Adam L; Taylor D; Yang R; Sleph P; Chen AYA; Yin X; Wexler R; Salvati ME
Bioorg Med Chem Lett; 2016 Jul; 26(14):3278-3281. PubMed ID: 27256912
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a Lead Triphenylethanamine Cholesterol Ester Transfer Protein (CETP) Inhibitor.
Finlay HJ; Jiang J; Rampulla R; Salvati ME; Qiao JX; Wang TC; Lawrence RM; Harikrishnan LS; Kamau MG; Taylor DS; Chen AYA; Yin X; Huang CS; Chang M; Chen XQ; Sleph PG; Xu C; Li J; Levesque P; Adam LP; Wexler RR
ACS Med Chem Lett; 2019 Jun; 10(6):911-916. PubMed ID: 31223447
[TBL] [Abstract][Full Text] [Related]
13. Effects of CP-532,623 and torcetrapib, cholesteryl ester transfer protein inhibitors, on arterial blood pressure.
Blasi E; Bamberger M; Knight D; Engwall M; Wolk R; Winter S; Betts A; John-Baptiste A; Keiser J
J Cardiovasc Pharmacol; 2009 Jun; 53(6):507-16. PubMed ID: 19455053
[TBL] [Abstract][Full Text] [Related]
14. 2-Arylbenzoxazoles as CETP inhibitors: raising HDL-C in cynoCETP transgenic mice.
Kallashi F; Kim D; Kowalchick J; Park YJ; Hunt JA; Ali A; Smith CJ; Hammond ML; Pivnichny JV; Tong X; Xu SS; Anderson MS; Chen Y; Eveland SS; Guo Q; Hyland SA; Milot DP; Cumiskey AM; Latham M; Peterson LB; Rosa R; Sparrow CP; Wright SD; Sinclair PJ
Bioorg Med Chem Lett; 2011 Jan; 21(1):558-61. PubMed ID: 21094047
[TBL] [Abstract][Full Text] [Related]
15. Chromanol derivatives--a novel class of CETP inhibitors.
Vakalopoulos A; Schmeck C; Thutewohl M; Li V; Bischoff H; Lustig K; Weber O; Paulsen H; Elias H
Bioorg Med Chem Lett; 2011 Jan; 21(1):488-91. PubMed ID: 21084191
[TBL] [Abstract][Full Text] [Related]
16. HDL metabolism and CETP inhibition.
Barkowski RS; Frishman WH
Cardiol Rev; 2008; 16(3):154-62. PubMed ID: 18414186
[TBL] [Abstract][Full Text] [Related]
17. Refocusing on use of cholesteryl ester transfer protein inhibitors.
Kastelein JJ
Am J Cardiol; 2007 Dec; 100(11 A):n47-52. PubMed ID: 18047853
[TBL] [Abstract][Full Text] [Related]
18. Novel tetrahydrochinoline derived CETP inhibitors.
Schmeck C; Gielen-Haertwig H; Vakalopoulos A; Bischoff H; Li V; Wirtz G; Weber O
Bioorg Med Chem Lett; 2010 Mar; 20(5):1740-3. PubMed ID: 20137927
[TBL] [Abstract][Full Text] [Related]
19. Cholesteryl ester transfer protein inhibition in cardiovascular risk management: ongoing trials will end the confusion.
Kappelle PJ; van Tol A; Wolffenbuttel BH; Dullaart RP
Cardiovasc Ther; 2011 Dec; 29(6):e89-99. PubMed ID: 20645987
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and structure-activity-relationship of 1,5-tetrahydronaphthyridines as CETP inhibitors.
Fernandez MC; Escribano A; Mateo AI; Parthasarathy S; Martin de la Nava EM; Wang X; Cockerham SL; Beyer TP; Schmidt RJ; Cao G; Zhang Y; Jones TM; Borel A; Sweetana SA; Cannady EA; Stephenson G; Frank S; Mantlo NB
Bioorg Med Chem Lett; 2012 May; 22(9):3056-62. PubMed ID: 22497761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
